In the current study, we now provide evidence that the acidic tumor milieu promotes LD accumulation by DCs in response to secreted TGF-β2, leading to a profound metabolic rewiring that alters their migratory potential to lymph nodes and impedes their immunostimulatory activity. The gene discussed is TGFB2; the disease is neoplasm.